Revolution Medicines纳斯达克IPO首日开盘上涨66%_老虎社区_美港股上老虎

Revolution Medicines纳斯达克IPO首日开盘上涨66%

新浪美股2020-02-14

北京时间2月14日消息，Revolution Medicines，Inc．$(RVMD)$上市首日开盘交易价为28.21美元，较发行价每股17美元上涨66%。该公司在纳斯达克（Nasdaq）上市，股票代码为RVMD。Revolution Medicines是一家处于1/2期的肿瘤生物技术公司，开发RAS通路抑制剂。该公司以每股17美元的价格发行了1400万股股票，筹资2.38亿美元。摩根大通（J....

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

暂无评论

热议股票

7x24

全部

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2011379986?lang=zh_CN&edition=full","thumbnail":"https://static.tigerbbs.com/3153c88188d79bb8182b93c4fdd43636","is_english":false,"pubTime":"2020-02-14 00:53","share_image_url":"https://static.laohu8.com/b0d1b7e8843deea78cc308b15114de44","id":"2011379986","market":"us","top_or_hot":-1,"title":"Revolution Medicines纳斯达克IPO首日开盘上涨66%","media":"新浪美股","content":"<div>\n<p>北京时间2月14日消息，Revolution Medicines，Inc．$(RVMD)$上市首日开盘交易价为28.21美元，较发行价每股17美元上涨66%。该公司在纳斯达克（Nasdaq）上市，股票代码为RVMD。Revolution Medicines是一家处于1/2期的肿瘤生物技术公司，开发RAS通路抑制剂。该公司以每股17美元的价格发行了1400万股股票，筹资2.38亿美元。摩根大通（J....</p>\n\n<a href=\"https://finance.sina.com.cn/stock/usstock/c/2020-02-14/doc-iimxxstf1238006.shtml\">网页链接</a>\n\n</div>\n","source":"sina","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Revolution Medicines纳斯达克IPO首日开盘上涨66%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRevolution Medicines纳斯达克IPO首日开盘上涨66%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2020-02-14 00:53 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.sina.com.cn/stock/usstock/c/2020-02-14/doc-iimxxstf1238006.shtml><strong>新浪美股</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2月14日消息，Revolution Medicines，Inc．$(RVMD)$上市首日开盘交易价为28.21美元，较发行价每股17美元上涨66%。该公司在纳斯达克（Nasdaq）上市，股票代码为RVMD。Revolution Medicines是一家处于1/2期的肿瘤生物技术公司，开发RAS通路抑制剂。该公司以每股17美元的价格发行了1400万股股票，筹资2.38亿美元。摩根大通（J....</p>\n\n<a href=\"https://finance.sina.com.cn/stock/usstock/c/2020-02-14/doc-iimxxstf1238006.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"QQQ","symbol_name":"纳指100ETF","start_time":0,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2020-02-14/doc-iimxxstf1238006.shtml","article_id":"2011379986","we_media_id":null,"thumbnails":["https://static.tigerbbs.com/3153c88188d79bb8182b93c4fdd43636"],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/usstock/c/2020-02-14/doc-iimxxstf1238006.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2011379986","pubTimestamp":1581612780,"sourceInfo":{"source_id":"sina","name":"sina"},"weMediaInfo":null,"summary":"北京时间2月14日消息，Revolution Medicines，Inc．$(RVMD)$上市首日开盘交易价为28.21美元，较发行价每股17美元上涨66%。该公司在纳斯达克（Nasdaq）上市，股票","collect":0,"end_time":0,"defaultTopTitle":"sina.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"QQQ":"纳指100ETF","QID":"纳指两倍做空ETF","PSQ":"纳指反向ETF","TQQQ":"纳指三倍做多ETF","QLD":"纳指两倍做多ETF",".IXIC":"NASDAQ Composite","03086":"华夏纳指","SQQQ":"纳指三倍做空ETF"},"translate_title":"The Nasdaq IPO of Revolution Medicines opened 66% higher on its first day.","themeId":null,"isJumpTheme":false,"ttsUrl":"https://static.tigerbbs.com/c647c9040dc0db03ae3e0cde4d054a0f","symbols_score_info":{".IXIC":0.6,"03086":0.6,"PSQ":0.6,"QID":0.6,"QLD":0.6,"QQQ":0.6,"SQQQ":0.6,"TQQQ":0.6},"content_text":"北京时间2月14日消息，Revolution Medicines，Inc．$(RVMD)$上市首日开盘交易价为28.21美元，较发行价每股17美元上涨66%。该公司在纳斯达克（Nasdaq）上市，股票代码为RVMD。Revolution Medicines是一家处于1/2期的肿瘤生物技术公司，开发RAS通路抑制剂。该公司以每股17美元的价格发行了1400万股股票，筹资2.38亿美元。摩根大通（J.P． Morgan）、考恩（Cowen）、SVB Leerink和古根海姆证券（Guggenheim Securities）担任此次交易的牵头承销商。","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}